Monday, December 29, 2014

Weekly links 20 december 2014

 “MUST READ”
TOOLS/TECHNIQUES
o    Antibodies are one of the most important tools in molecular biology. Regardless of what species, cell type, or organ system you are studying, it is almost inevitable that you will use an antibody-based assay at some point
Here is a quick review of the key concepts for antibody use in your molecular biology lab

HEALTH/MEDECINE
o    It will be the first of four newborn-sequencing studies that each received multimillion-dollar grants from the US National Institutes of Health (NIH) in September 2013. The studies will address both the feasibility and the ethics of a process that could soon become standard for inexplicably ill newborns.
The problem is that many patients think genetic testing can tell us far more than it does. Despite the exaggerated claims of some entrepreneurs and lab owners, we can’t predict patients’ cancer risk and advise them appropriately just by sequencing their genome. At least

COMPANIES
o    Bioinformatics giant Illumina (NASDAQ: ILMN) is getting into the accelerator game, along with other players in the life sciences and other fields. On Wednesday it announced the first three startups chosen to start the program this fall at its San Francisco lab space.
SOMETHING DIFFERENT
o    Lately, Paleo has charged toward the mainstream, not only as a hugely popular diet (it was most-searched diet of 2013, according to the Google Trends Zeitgeist list), but also as a cave-man-inspired lifestyle that has spawned a fast-growing industry.
o    Before he left, however, he wrote this essay on creativity as his single formal input. This essay was never published or used beyond our small group. When I recently rediscovered it while cleaning out some old files, I recognized that its contents are as broadly relevant today as when he wrote it. It describes not only the creative process and the nature of creative people but also the kind of environment that promotes creativity.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)